HES6 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Hairy and Enhancer of Split 6 (HES6), a member of the HES family of basic helix-loop-helix (bHLH) transcription factors. Unlike other HES proteins, which generally function as transcriptional repressors, HES6 acts as a transcriptional cofactor that promotes gene expression by interacting with other transcription factors, particularly those involved in neurogenesis and cell differentiation. HES6 plays a significant role in regulating the Notch signaling pathway and other cellular processes by modulating the expression of genes involved in developmental pathways. Inhibition of HES6 disrupts its ability to influence gene transcription, thereby impacting the regulation of cellular differentiation and growth.
Chemically, HES6 inhibitors are designed to interfere with HES6's protein-protein interactions or its ability to bind to DNA. These inhibitors may act by binding directly to the bHLH domain of HES6, preventing it from forming complexes with other transcription factors, or by allosterically altering its structure to hinder its function. Structure-activity relationship (SAR) studies and high-throughput screening methods are often employed in the development of these inhibitors, allowing researchers to identify compounds that exhibit high selectivity and potency for HES6. By inhibiting HES6, these compounds are useful tools for studying the intricate networks of transcriptional regulation, particularly in processes like neural development and cell fate determination. Additionally, they enable detailed exploration of the specific role HES6 plays in the broader context of transcription factor-mediated gene regulation.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
A γ-secretase inhibitor, DAPT may indirectly influence HES6 by modulating Notch signaling, which regulates HES6. | ||||||
LY411575 | 209984-57-6 | sc-364529 sc-364529A | 10 mg 50 mg | $194.00 $464.00 | 6 | |
Another γ-secretase inhibitor, LY411575, could affect HES6 activity through Notch signaling pathways. | ||||||
RO-4929097 | 847925-91-1 | sc-364602 sc-364602A | 10 mg 50 mg | $430.00 $1389.00 | 1 | |
RO4929097, a γ-secretase inhibitor, may indirectly modulate HES6 by altering Notch pathway activity. | ||||||
BYL719 | 1217486-61-7 | sc-391001 sc-391001A sc-391001B sc-391001C sc-391001D sc-391001E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $383.00 $585.00 $740.00 $1169.00 $4902.00 $9186.00 | 2 | |
As a γ-secretase inhibitor, PF-03084014 could impact HES6 by influencing Notch signaling. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin can modulate numerous signaling molecules, potentially affecting HES6-related pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin, an mTOR inhibitor, might indirectly affect pathways that intersect with HES6's role. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542, an inhibitor of the TGF-β receptor, may indirectly affect HES6, given its role in developmental processes. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059, a MEK inhibitor, could impact HES6 through the MAPK/ERK pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, may influence pathways associated with HES6's function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
As a JNK inhibitor, SP600125 could influence pathways related to HES6, especially in neurogenesis. |